[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4966 followers Created: 2025-07-20 14:20:56 UTC 🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists In SELECT (Kushner 2025), semaglutide XXX mg reduced serious adverse events in obese CVD patients. GI side effects caused higher discontinuation. #SELECT #safety $NVO $SNY XX engagements  **Related Topics** [$sny](/topic/$sny) [events](/topic/events) [$mngl](/topic/$mngl) [longterm](/topic/longterm) [weight loss](/topic/weight-loss) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [sanofi](/topic/sanofi) [Post Link](https://x.com/AponiaAnalytics/status/1946938377426849879)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4966 followers
Created: 2025-07-20 14:20:56 UTC
🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists
In SELECT (Kushner 2025), semaglutide XXX mg reduced serious adverse events in obese CVD patients. GI side effects caused higher discontinuation. #SELECT #safety $NVO $SNY
XX engagements
Related Topics $sny events $mngl longterm weight loss $nvo stocks healthcare sanofi
/post/tweet::1946938377426849879